Author: Sarma, Aartik; Christenson, Stephanie A.; Byrne, Ashley; Mick, Eran; Pisco, Angela Oliveira; DeVoe, Catherine; Deiss, Thomas; Ghale, Rajani; Zha, Beth Shoshana; Tsitsiklis, Alexandra; Jauregui, Alejandra; Moazed, Farzad; Detweiler, Angela M.; Spottiswoode, Natasha; Sinha, Pratik; Neff, Norma; Tan, Michelle; Serpa, Paula Hayakawa; Willmore, Andrew; Ansel, K. Mark; Wilson, Jennifer G.; Leligdowicz, Aleksandra; Siegel, Emily R.; Sirota, Marina; DeRisi, Joseph L.; Matthay, Michael A.; Hendrickson, Carolyn M.; Kangelaris, Kirsten N.; Krummel, Matthew F.; Woodruff, Prescott G.; Erle, David J.; Calfee, Carolyn S.; Langelier, Charles R.
Title: Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS Cord-id: sruvtkpb Document date: 2021_8_26
ID: sruvtkpb
Snippet: The immunological features that distinguish COVID-19-associated acute respiratory distress syndrome (ARDS) from other causes of ARDS are incompletely understood. Here, we report the results of comparative lower respiratory tract transcriptional profiling of tracheal aspirate from 52 critically ill patients with ARDS from COVID-19 or from other etiologies, as well as controls without ARDS. In contrast to a “cytokine storm,†we observe reduced proinflammatory gene expression in COVID-19 ARDS w
Document: The immunological features that distinguish COVID-19-associated acute respiratory distress syndrome (ARDS) from other causes of ARDS are incompletely understood. Here, we report the results of comparative lower respiratory tract transcriptional profiling of tracheal aspirate from 52 critically ill patients with ARDS from COVID-19 or from other etiologies, as well as controls without ARDS. In contrast to a “cytokine storm,†we observe reduced proinflammatory gene expression in COVID-19 ARDS when compared to ARDS due to other causes. COVID-19 ARDS is characterized by a dysregulated host response with increased PTEN signaling and elevated expression of genes with non-canonical roles in inflammation and immunity. In silico analysis of gene expression identifies several candidate drugs that may modulate gene expression in COVID-19 ARDS, including dexamethasone and granulocyte colony stimulating factor. Compared to ARDS due to other types of viral pneumonia, COVID-19 is characterized by impaired interferon-stimulated gene (ISG) expression. The relationship between SARS-CoV-2 viral load and expression of ISGs is decoupled in patients with COVID-19 ARDS when compared to patients with mild COVID-19. In summary, assessment of host gene expression in the lower airways of patients reveals distinct immunological features of COVID-19 ARDS.
Search related documents:
Co phrase search for related documents- absolute value and acute respiratory failure: 1
- absolute value and low expression: 1, 2
- activation state and acute ards respiratory distress syndrome: 1, 2
- activation state and acute illness: 1, 2
- activation state and acute respiratory failure: 1, 2, 3
- activation state and low expression: 1, 2, 3
- acute ards respiratory distress syndrome and additional analysis: 1, 2, 3
- acute ards respiratory distress syndrome and additional study: 1, 2, 3, 4, 5
- acute ards respiratory distress syndrome and low airway: 1, 2, 3, 4
- acute delirium and additional analysis: 1
- acute illness and additional analysis: 1
- acute illness and additional study: 1, 2, 3
- acute respiratory failure and additional study: 1, 2, 3
- acute respiratory failure and low airway: 1
Co phrase search for related documents, hyperlinks ordered by date